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The Interaction between Blood Platelets and
Blood Coagulation Factors
Bi,J. L. M. L. van Rijn. J. Rosing. G. r.an Dieijen. E. N{. Ber,'ers. R. F. A. Zwaal. and H' c' Hemker
Summary: Prothrontbin at ' t i t 'ut i t t t t  ancl intr i t tsi t '  lat ' trsr X'
ctct i t 'ctt ion are greatl t  st i tnulatet l  ht thc presott ' t '  ol  t tegutive-
It '  t ' l targetl  phospholipids ancl rton-ett:vntat ic proteln ( 'o-
fArror.s i.lactor I'ci lbr prothrombitt- urul t'ht'tor.L'lllct.lor lat'-'tor 
X artit'cuittn). Sttrtlies in motlel .tl'.tlerr? shox' thcil phtts-
nhtt l ipicls I) tot l t() tL'  thc assentblr of ' the prtt t l trontbin- antl  . lLtt ' -' tor 
i  act i t ' t t t i t tg (ot i lple.\( ' \  utt t l  t l tul  t l tc t t t t t t- t ' t t : . t ' t t lLl l i (  l t t 'L)-
riin cot'actors fhau, i'o antl fttt'tor l'lllct cnhant'e the catalt'-
tic actit,itr of' fat'tor Xa antl lactor IXu' re.spe.t'tivelr' In.vit'o'
floid ptiteieis tikclr prot'itle the. prococtgLtlcLnt ntt:mhrane
tri*,i req ui recl .fbr' t'iagtLlttt i o rt fht' l or at'.t it'ctt io n' T he effbct
of"human' platelets in l trothrttnthin- attd intr insit ' .  lhctor.,X.
i'rt:iiitii"'tra.s claterminec! in u.ssat' r-1'.rIe17?.! ttith purified
ciasulation lactors. C ct nparetl t'i t h u tt.sti n'ttLlate d p lat e I et s'
piitiiLtott triggered r'ith collctgen plus thlontbin shov'ecl ct'10-20fbtct 
nitirit, int'rcase in ltrothro.mbin 
.ancl litt'tor X
activation. Treatinent ol the stitnttlata(l platalett uith plto's-
oholina.se dAz aholi.vhecl both at'tit'ities. This inclicate's, thcrt'u: 
n o, n p late let fi i m tt I at i o n. p h o s p htt I i p i cl s ( p ar t i c u lar I t' p ho s -
p'hariit'lserine) e.rposetl at the platelet outer tttemhrane are
' 
a.n e s.se nl i al c o n1 p'o ne nt o.l' th e p I a t e I ct p r ot' ott gu la nt s t t jac e'
Zusammenfassung; l nlerctkliort :rt'ischen B|utp\tittt'hen ttntl
B lu t ge r i n rt tut gsla kt o re n
Die inrr insist 'he .- lkr i t ' iert t t tg t t tn Faktot X und cl ie ' lkt ivie-
rung von Proi l trotnhin t 'etden in ' lnv'esenltett  wn negatlv ge'
Key words : B I ort d c o u gtt Iat i o n ./ix' t or'\, i n t c rac t i o n vi t h p I ate le t's
1 The blood coagulation cascade
Blood coagulat ion is caused by a series of sequentiai proen-
zyme-enzyme converslons. In a mixture of trypsinogen and
.i .ry*ottyptinogen the addit ion of a small  amount of entero-
kinase would ciuse the activation of one enzyme, that then,
in i ts turn would activate the other, thus causing a primit ive
cascaae. In the blood coagulat ion the mechanism is much
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Fig. l: The basic blood coagulatton sequence
lctdenen Phospholipiclen trnd Protein-Ko/aktttren (Faktor
fl11., l i ir l ie'.4lit i t ' ientng ron Faktor X und Faktor l" '  ft ir
tlie t'on Prothromhin) stark beschleunigt'
,l[otlelIttntersLrchttngen zeigten. claJ3 Plnspholipicle die Bil-
tlttng t't1n Prothroribin- und Faktor 'Y-uktirierenden Kom-
:pleren 
./iirclern und daJ3 die Kolitktor'9n . Vu trnd L'lll "'tlie 
katalt'tist'he Wirkung von Faktor X,,.h:.tt" Faktor IX"
erhijhen. I n t'it'o sorgen hiichstv'ahrscheinlich Blutplcittclrcn
iti, ii, prokoagulieiinclen Menthrctnstnrkturen, tt'elche liit
clie .4krit'ierttng yon clen Gerinnungsfakloren bendtigt v'er-
den.
Der Einflul3 t'on Blmplcittchen attf die Aktivierung votl
Prorhrombin ttnd Faktor X tvurde mit gereinigtem Getin-
nungslaktoren getestet. In Vergleich alt den rticht-
sti,ri.,,iierte, Btutptcittchen, zeiSten jene, clie mit Kollagen
iiittt Thrombin siimuliert uwrden, eine I0- bis 2}Jitche hri-.
h.erle ,lktivit i i t bei cler Akrit ' ienmg von Prothromhin trnd
iaktor X. Werden clie stimulierten Blutpldttchen mit Phos-
pholipa.se Az behanclelt, so .fiihrt dies :tt einer Zerstorung
lcr  Akt i r i r t i t .
Dies :eigt, cta13 ctie Phosphotipide (besonders Phosphati-
t lvlserin)'. 'v'elcie sich nach Stimttl ierung bei den Pli ittchen
cttrl' cler AttBenmembran be.finden' Y'esentliche Komponen'
ten der proioagulierenden Obeilciche hilden'
. Plutclcts, interaclion v'ith couqltlation factors
more refined. In principle a three step cascade does explain
iiii""rUl" formation: tiisue thromboplastin converts lactor
Viii"t" f^.t"r VII.; factor VII, activates factor X; factor.Xu
;;;;;;r ;;"ihrombin to form thrombin' In this mechanism
Itr... it a reinforcement loop involved because factor VII.
ulro-u.tiuut.t factor IX, and lactor IXu acti^vates factor X'
This loop causes appreciable amounts of factor X to be
;;i;"il, .u.n in the presence of onty minute amounts of
tiiir. tft.b-Uoplastin (Fig. t I' Apart from.the activation by
ir.t"r Vff", factor IX cunllso be activated by factor XIu that
ilr"f l it ioimea by the so called contact activation' This me-
.f't"tii- 
"^pfainiwhy 
piatelet free plasma without a trace of
iirt". itt."-U"plastin will clot in a glass tube' Its physiologi-
cal significance is iess clear.
Several reactions in the blood coagulation reaction sequence
require the presence of so-called non-enzymatic olactors'
i-fr-.r.ioiu.tbrs are divided in two classes: 1, protein cofac-
tors, 2, negatively charged surfaces'
It is generally known that these non-enzymatlc colactors
ni"utfi enhance the rate of the clotting factor activation
;;;; i i ;"; in which thev participate. The reactions and their
.oluitt.t are summariied in Table 1' Their place in the co-
asulation scheme is indicated in Fig' 2'
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Fig, 2: Blood coagulation sequence with modulators.
Table 1: Phospholipid ependent reactions in blood coagulation.
Enzyme
Factor Vilg
Factor VIIs
Factor IXa
Factor Xa
Protein cofactor
Tissue factor apoprotein
Factor VIIIa
Factor Va
,
q
lenzyme I  Xo,  lXo) ? subslrote (  PT,X )? produr i ( l lo ,X0)
a) The extrinsic factor X activation.
^ )  T h e  i n t r i n s i c  l a c t o r  X  a c t i r a t i o n .
pl = phospholipid. The velocitl obtained b-l iactor X3 alone is arbitrari l l  dc
hned as unity.
Fig. -j: Model for the prothrombin and fbctor
phospholipid is represented as a bilaler and
headgroups.
X activating cpmplexes. The
contains nefatively charged
' tab le  3 :  Enz tme k ine t ic  cons tan ts  o fp ro th rombin  and fac to r  X  ac t iva t ion
Pro thrombin  ac t i \a to r Km prothrombin(Pmol i  I )
Vmax( l l a .m in - l  .  Xa - l )
Xa.  Cal+
Xa. Cal+.  phosphol ip id
Xa. Car+.  phosphol ip id.  Va
lJ4
0.06
0 . t  I
0.68
2.3
t 9 t 9
Factor X acti\ alor Km {ac tor  X( t  mo l  1 )
Vmax
(Xa .  min- l  IXa- l  )
IXa.  Cal*
tXa.  Ca]+.  phosphol ip id
IXa.  Car+.  phosphol ip id.  VI I Ia
l 8 r
0.06
0.06 3
0 .01
0.002 s
500A quantitative study of these reactions has become possible
beciuse the proteins involved can now be obtained in a pure
state in large enough quantities and because the products of
the reactions can be determined spectrophotometrically with
high accuracy due to the development ofthe so called chro-
mogenic substrates (ref. I l]).
Table 2 shows the effect of factor Va, C42+ and phospholipid
vesicles on the rate of prothrombin activation. Factor Va
and negatively charged phospholipids timulate prothrom-
bin acti"vation'by facior Xa independently and multiply th.eir
effects. With the complete prothrombinase complex. consist-
ins of lactor Xa, lactor Va, Ca2* and phospholipid. a
2d000fold rate enhancement is observed. Similar obser!'a-
tions are made for the effect of cofactors in intrinsic and ex-
trinsic factor X activation and the reactions of the contact
activation system.
There exist extensive similarit ies between prothrombin and
intrinsic factor X activation. The substrates in both reac-
tions (prothrombin and factor X) are highl-v homologous
vitamin K dependent proteins. At their N-terminal end the)
contain /-carboxy glutamic acid residues, responsible for the
Car* dependent binding to negativell '  charged phospholipid
surfaces. The enzl'11s5 (factor Xa and lactor IXa). are also
homologous vitamin K dependent proteins. The protein co-
lactors (factor Va and lactor VIIIa) have no enz)'matic acti\-
ity and have a high affinit-v for negative phospholipid sur-
faces. although thel' lack /!-carboxy glutamic acids. A gen-
eral model for the prolhronlbin and factor X acti\ ating com-
plexes is shorvn in Fig. 3. Phospholipids promote the assem-
bl1 'of  the enzl tne-cofactor-substrate complex v ia the in ter-
actions of clotting lactors with the plrospholipid surlace and
via direct interaction. The rate measuremenls do explain the
necessit),ofthe colactttrs but thel do not pernrit conclusiorls
about the mode of action of the accessoil '  tactors in the en-
zyrnatic mechanisrn of clotting l 'actor activation. Therefore
we determined the effects of accessory components on the
kinetic parameters ol prothrombin and intrinsic lactor X
2
activation [2. 3].  This is the f irst step in elucidating the role
of accessory components in the mechanism of coagulat ion
lactor act ivat ion. The kinetic parameters of prothrombin
and intr insic factor X activation. observed for enzyme com-
plexes of var] ' ing composit ion. are summarized in Table 3.
Frothrombin and lactor X activation are very ineff icient
processes. The turnover number of substrate molecules by
the completel-v saturated enz)/me (Vrnax) is very low and the
substrate concentrat ion causing half maximal reaction velo-
cit l  Km for prothrombin and lactor X are considerably
higher than the respective plasma concentrat ions (prothrom-
bin 2 4moli  l .  lactor X 0.2 gmol./ l ) .  The presence of phos-
pholipid plus Cart causes. in both complexes. a drastic drop
of the Km to values below the plasnla concentrat ions, while
the protein colactors greatl l  increase the Vmax.
2. \ \ 'hy are phospholipids necessarl ?
Since this paper deals with platelet involvement in blood
coagulat ion rve rvi l l  not further discuss the effects olthe pro-
tein cofactors. Both in prothrombin and intr insic lactor X
activation. phospholipids cause a drastic drop of the Km for
prothrombin and lactor X. respectivel l .  Furthermore the
KnT shor. l 's an increase with a r ise of the phospholipid
concentrat iol l  present in the reaction mixture (Table '1). So
the Krn. measured in the presence of phospholipid. rnust be
ain apparent Km and is not. as such. a reaction constanl of
ihe  ac t iva t ion  under  s tud l ' .  A  rnode l  tha t  can  exp la in  bo th
t l ie  d rop  o i 'Knr  and the  apparcn t  charac le r  obser rcd  in  the
presencc ol 'phospholipid is preserrtecl in Fig. '1 ln l iee solu-
t ion. enz1.r.uc ( lactor Xa or l i tctor IXa) and substrate (proth-
rombin or lactor X) have a lou' af l ini t l '  for each other. and
therefore show a high Krn. With negatir"el l  charged phos-
pho l ip ids  p resen l  in  the  reac t ion  rn ix tu re .  bo th  the  enz !n les
, o '
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Factor II
Table 2: Effect ofcofactors on the rate ofthrombin lormation
Factor Xa
Faclor Xa + Caf+
Factor Xa + Cal-++ PL
Factor Xa + CA-++ factor Va
Factor Xa + Cal*+ PL + factor V,A
Fig . , l :  Poss ib le  n rode o l 'ac t ion  o l 'phospho l ip ids  in  b lood coagu la t to t l
tab le  . l :  E i lec t  o iphospho l ip id  co l l cen l ra t io l l  on  Michae l is  co l l s tan ts '
Pro thrombin  ac t r \a t ton ln t r ins ic  fhc to r  X  ac t iVa t ion
thcse i *  o.  This  causes the same et lect  as an lncrease
in concentration of the substrate would do. Half marimal sa-
turat ion of  phosphol ip id bound enz)"me wi th substrate '  is
reached at a lnuch lower substrate concentratlon because lI
is  determined b i  the prothro lnbin concentrat ion at the phos-
pholipid surtace. Also the dependency' of the apparr::nt Kn.l
on the phosphol ip id col lcentra l ion cal l  be expla ined b1 - th is
model: 'To attain the same prothrombin densitl at the phos-
pholipid surlace at higher phospholipid concentratlons'
more'prolhrombin is required. It can be expected that' al-
though the apparent Km increases r'vith the phosphoiipid
concEntration. a Km expressed in terrns of surlace densitl of
phospholipid bound substrate, would be constant' Using
kno*n UinOing parameters for prothrombin and lactor X
binding to phoipholipid vesicles [4], w9 
.calcuiated the
concen"tration of iubstiate bound per gmol/l phospholipid'
at the Km's presented in Table 4. Fig. 5 shows the results'
lndeed the Km expressed in terms ol phospholipid bound
substrate is independent of the phospholipid concentratlon'
which supports (but not proves) the proposed model'
The activity of phospholipids is dependent upon their
composition-. In procoagulant membrane-s' net negatively
charged phospholipids have to be present' Neutral phospho--
ItptOi 
".. 
inactive. Furthermore a l iquid crystall ine state ol
the membrane is required for an optimal function in blood
coagulat ion act iv i t l  [51.
3. Platelets as a source ofprocoagulant surface
Under physiological conditions wounded cells and intact
otut.t.ti irovidi the phospholipid surlace required for
prothrombin and intrinsic lactor X activation. The proco-
igulant activity of platelets is known as platelet lactor 3'
We wil l not diicuss here the possibil i ty that platelets init iate
contact activation [6, 7]. Intact non-stimulated platelets are
ho*.u.. inactive in clotting lactor activation (Table 5)' In
model experiments, rates of prothrombin activation were
determined with vesicles composed of the phospholipids
present in the platelet membrane. When the net negatively
iharged phospLolipids (phosphatidylserine and phosphati-
dvlir iositol) at. omitted from the vesicles in which the phos-
pit.flpiO composition of the platelet plasma membrane is
*i*l.t.a. a low rate of prothrombin activation is measured'
l  ab le  5 :  Phospho l ip id  compos i t ion  in  p ro th rombinase '
Phosphol ip id(1rmol  )
t . 6
1 0 . 5
16 .3
5 1 . 6
7 5
1 0 5
t.l0
aDD = ADparent .
I n  t h i s  c r p e r i n r e n l  n o  l J u l o r  V J  o r  l a c l o r  \  l l l ; 1  r r l '  a J J c J
I O
l0
50
7 5
i00
l - 50
100
-100
Km app
(/mol i  l )
0 . 05  8
0 . 1 3 9
0 .3  6 l
0. ,+09
0 .51  5
0 .811
1 . 8 3
1 . 7 6
and substrates bind to the phospholipid surlace. This makes
a reaction possible between bound enzyme and bound sub-
strate and thus lavours the number of coll isions betrveen
20
20
20
l0
30
30
I
a
=
o
=
E
9 l
=
I
6
E
Y
E
. 0  X
a
! <
o <
a
=
-o
o
E
Y
Ves ic le  compos i t ion  lmo l  'Yo)
Plateiet phospholiPid extract
Platelet sonicate
Thrombin fbrmation(nmoir l  l la  min- ' )
J 4
1 l 9 r
23
I  1 6 8
I 176
1 0 0
P H O S P H O L I P I O  ( ! M )
PS = Phosphat id-v lser ine.  PI  = Phosphat idyl inosi to l .  PC.= Ptosphat idylchol i -
n. .  pe = P'hosphi t idy lethanolamine.  Sph = Sphingomlel in Vesic le and plate-
r . i 'or ,o.pr ,o i iJ iJ iorrcentrar ion is  I  pmol  l .  prothrombin 4 gmol I  lactor  Va
l0 nmol '  I .  la i tor  Xa I5 nmol I
In contrast, artificial vesicles with a phospholipid composi-
tion identical to that found in platelets and also vesicles
made from a complete platelet phospholipid extract, give
high rates of prothrom6in activation. Table 5 therefore
sh"ows that the net negatively charged phosphatidylserine is
essential prothrombin activation. It is important to note
however that phosphatidylserine is almost exclusively locat-
ed in the inner monolayer of the platelet membrane [8]' l t
can lor instance be exposed to ciotting factors in the reaction
mixture if the platelets are lysed by ultrasonication (Table
:). t-VseO plateiets exhibit the same prothrombin activation
rates'as visicles composed of platelet phospholipids' This
suggests that only phosphatidylserine contributes to the en-
ha'nlement of piothrombin activation by lysed platelets'
When intact plitelets are stimulated with the physiological
platelet triggers, collagen or thrombin, small rate enhance-
h.nt. u." heasured in assay systems for prothrombin and
3 0 0
PHosPHoL lP lD  ( !M )
Fie, 5: Effect of phospholipiC concentration on the apparent Km' and the
k'ilr 
""o*tr.a 
in sub:fritc surface density fbr prothrombin (A) and intrinsic
factor X activation (B).
Km app
( i r  mol ,  l )
Choles tero l  (u  u  )
-  l s 0
-  1 3 1 4 7
t 0  I  3  |  3 7
Intact platelets
6: Role of plateiet stimulalion in thrombin and factor Xa formation'
Prothrombin activation
(nmol r ' l  l l a  min- '' latelets stimulated bY
Factor X actlYatlon
(nmol l l  Xs  min- ' )
Thrombin (1.3 nmol/l)
Collagen (10 pglml)
Thrombin (1.3 nrnol/l)
plus collagen (10 Pglml)
Concentrations: 4 pmolll prothrombin' 15 nmol"l Xa' 30 nmolll Va for
i-ir]-ri]ii,ui" iitivaiion; 0.i pmol/l X, 150 nmolil IXa. l5 nmol/l vllla for
factor X actlvatlon.
activating complex are calculated. These numbers are so
.iot. to Jach other. that they strongly suggest that, the same
;it.t fi;ti;; in prothrombin and factor X activation at the
surface of stimulated platelets. This observation suggests
that the essential component for the binding of the protetns
;f th. p;;thro;bin ind the intrinsic factor X activating
.o*pl.i.t ii the phosphatidylserine that after platelet trig-
g.i ing U..o-es exposed in the outer monolayer of the mem-
6runJ. th. time course of the appearance of .procoagulant
u.iiuity in stimulated platelets can be followed in the assay
;;;i.;1 io. Jtoth.o*bin and intrinsic factor X activation' In
Fig. O ttt" generation of a procoagulant.surface is followed at
saiurating factor Xa, Va and prothrombin concentratlons 1n
iir. p.ottito-bin activating assay, and. at sub-saturating fac-
tor iXa and VIIIa concenirations in the lactor X activating
i"tt..". Aalf *a*i*ul factor X converting activity is ob-
s6iveO witnin 2 min after addition of collagen plus throm-
bin, whereas prothrombin converting activity reaches the
half maximum value after 9 min. The observed ifferences
between the time courses at first sight seem to contradict the
idea. that the essential component of the procoaguiant sur-
face of stimulated platelets is exclusively phosphatidylserine'
We do think that they can be easily accomodated in our mo-
del. This lollows a.o. from phospholipase digestion experi-
ments. Platelets were stimulated with collagen plus throm-
bin ti l l  maximal procoagulant activity is reached and subse-
quently treated with N. naja phospholipase Az, an enzyme(no*n to degrade phospholiped molecules exposed at the
outer plateleisurface. Using high phosph^olipase .A2 concen-
i*tiont, both prothrombin ind intrinsic factor X converting
activit ies of thi stimulated platelets are completely abolished
within l0 min. The absence of leakage of lactate dehydro-
genase from the platelets during incubation with the phos-
iholiput.. indicaies that the platelet membrane remains in-
iu.t. 
'So 
the conclusion can be drawn, that procoagulant
phospholipids are an essential component.in the functional
i;t.t ' to. piothrombin and factor X activation on the stimu-
lated plaielet. When small amounts of phospholipase Az are
used, the time course of deca-v of prothrombin and factor X
.oni".t ing activit l '  ol the stimulated platelets- could be fol-
lowed. Aiter di{Ieient time intervals of phospholipase treat-
ment. the coagulation lactors are added to measure the re-
maining proco:agulant activity. It showed that the factor X
conver;ng actir'-iti' of platelets is more sensitive to phospho-
lipase treitment ihan- the platelet p-rothrombin converting
aitivity. This could be related to different phospholipid.re-
quirements. Therefore. prothrombin and lactor X activation
,"... -"u.ured in model systems' using phospholipid vesi-
cles with varying phosphoiipid composition. Prothrombin
and lactor X-converting activit ies are measured, using the
same coagulation lactoi concentrations as in the exp^eri-
*.ntt *iit.t platelets. The vesicles were compo.sed 
.of li-
pids at the same molar concentration as found in platelet
membranes. with the exception of phosphatidylserine and
ptrosptratiOylcholine. The mole fraction phosphatid.ylserine
ir uuii.d at the expense ofphosphatidylcholine and the over-
all phospholipid concentiation is kept at 2 pmol/l '  The
iatei. gi":en ai percentage of the maximal activity. measured
lor pr6thrombin and factor X activation at varying mo.l^e
p...'.ntug. phosphatidylserine. are given in Fig. 6' Large dif-
i...n"., in btrospfratiAi'lserine requi rement for prothromb in
activation aid l ictor X activation are observed' For the in-
trinsic lactor X activation. a molar fraction oll0% phospha-
tidl ' lserine is required for maximal activit l ' .  u'hereas for
prothrombin activation 2.5(/tr phosphatidl ' lserine is optimal'
At a surl-ace containing less than ?.50h phosphatidllserine'
lactor X activation rates are negligible. u'hile prothronibin
activation sti l l  proceeds at a considerab[' rate' This phe-
r"ronrelroll pror.ides the explanation lbr thc. obserrecl dil ler'-
encL-s in pLospholipase sensiti l i tr ot-sti lnulateci plateiets it l
prolhfonibin an<j ibctor X activation. Platelets stimulated
ivit l i  collagen plus thronrbirl e\pose 2i()ir ol 'their phosphati-
d1'lserinc at thc' platelet outer sutl-ace [8]. it can be calculatecl
that the overall n.role fraction phosphatidl ' lserine in the
intrinsic factor X activation (Table 6). Whe.n co.mpared with
r"rii-"t^i.O platelets, platelets triggered by lhe combined
;;t i;; ;acollagen plus ihrombin show a lOfold increase of
".ii"ii,.i" 
proihrombin activation and 2Ofold rate enhance-
..nr in factor X activation' Bevers et al' [8] found that
oiut.f.tt, which were triggered by the combined action of
i"f i"g." plus thrombin. Eposed their internallS localized
"ttoii lnutiovtterine 
to the membrane xterior' This introduc-
;;;";i-;h6tphatidylserine in the outer monolaver of^the
;hi.l.t'*.rnU.un.' (flip-flop) p^rodu.ces a platelet surface'
i"tti.tt p.ornotes the asJembiy of both-the prothrombin and
irtii"iii iactor X activating compiex bv binding of vitamin
i{ a.p.na.nt clotting factori. This explains.the-observed rate
."trui..*.nt of thr6mbin plus collagen stimulated platelets
in oiothrombin and factor X activation (Table 6)' Expen-
;.;i;; piesented in Table 6 can be used to quantitate the
;;;b.; o'i prothrombin and factor X activating compleles
on-itt. pf ut.i.t surface. The amounts of calculated sites (Ta-
bie 7) fbr unstimulated and thrombin activated platelets are
reiatively low as compared to the number found with colla-
*.r piri thrombin it imulated platelets' It is not clear
i"n.tfr.. unstimulated platelets, under physiological circum-
rtances, indeed have a low (but significant) amount of func-
iional binding sites. or that they have none. but that there
are parr ia l lu  ic t i ra ted p late lets  present  in .  the preparal ions '
XirS"ti^ pit i oittt i t ait ivitv must be attributed to the inevi-
table lysis'that occurs during platelet isolation procedures'
Fo-. tft. collagen plus thrombin stimulated platelet, approxi-
-ut.fy 26006 fu;ctional binding sLtgs^lo^r the prothrombin-
ui.-i6*pt.* and approximately 20000 for the factor X
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MINUTES AFTER PLATELET ACTIVATION
Fie.  6:  Time coursc ofappearance of  p late let  act iv i t t  in  prothromhin and c-
i.i-i ,clirlntion. Coaeuiaiion iactor concentrations: for protllrombin acti\a-
i i ; r .  t ; ; t ; i  iprothr"ombin.  lJ  pmol ' l factor  Xa'  30 4rnol ' l  Factor  Va'  fbr
t i ' i " ,  {o. i "ut tn.0.5 gmol I tactor  X.  50 smol l factor^ lXa and.O l gntol  I
ia . io,  r ; f f f r .  100", 'o act i r : i t r  in  prothrombin acl ivat ion is  800.pmol I  mrn- '
i i r ' io . . "6.  fOOua cr i ' i r , : in  l i rc tor  X acr ivat ion is  I7 pnrol ' l 'min- l  {actor
i i  fo.med. Platc lets $er;  s t imul : r ted ui th thrornbin p lus col lagen'
' Iable 7:  \umber o i 'act i rat lon . i tes on l tunran pldtc l t ' t  n lcrnbrane5'
Factor  \  ac l i \  r t iOD
(s i tes  p la te lc t )
.  
p r o t h t o m b i n  a c t i v a t i o n
Thrombin + coliagen
.  outer  monola\er  of  the p late let  is  at  most  j ( ) i r .  , {  modelphospholipid icsicle crcnti ining -5 11opr1{, pliosphaticil lserine
tvould shoi i '  a  rat io  of  lhe rates o l 'prot l r io t .nbin act i rat ior r :
and tactor  X act iva l ion of  l00:  l .  p late lc- ts  s t imulatec l  for  l
r l in  r i i th  thror lb in p lus coi lagen s l ror ,u.a r .a lucd of  t_ i :  I  for
tl,. is ratio. Therelore the pl'rospharidl lseriirc !-rposed ai the
ouie r sur lace o l ' the col lagen p lus thrombin sr imulated p late_
let .  cannot  be randont l i .  d is t r . ibutec l  in  the outer  monolaver .
of  the p late ler  membrane.  Domajns wi th h igher .  , r - f .  # i -centage phosphat idr  lser ine musl  ex is t  in  the outer  mono_lavel  of ' the p late let  membrane af ter  s t imulat ion w. i th  col la_gen plus thrombin in order to r-nake the observed ratio ol-prothrombin and lactor X activation rates possible. Most of
these phosphatidl, lserine enriched domains ar"e lormed r.i,, i th_
in 3 min after platelet stimulation. as can be concluded
lrom the time course of generating lactor X converting acti\Lity. Afte^r 3 min platelet stimulation. most ol the prJcoagu_
Iant s.urlace for prothrombin activation has sti l l  to be made(ct. Frg. 6). Based on these observations. we propose that thephosphatidy.lserine. exposed at the surlace of iollagen plus
thrombrn.st imulated p late lets ;  is  not  homogeneousl l ,  d is t r i -buted rn the outer  monolayer  o l  the p late let  membrane.  Do_
marns with. high phosphatidylserine densitl . u.,hich rapidl-v
appear at the surface of stimulated plateleis. are meaiuredpredominantly with the factor X activating svstem and to a
minor extend with the prothrombin activit ing s1.stem. Do_
mains wirh Iow.phosphat idy lser ine densi r l .  "which appear
srower.  can only be measured by the prothrombin act i r :a t ing
systemr It is not yet known what mechanisms and co*pol
nents govern the lateral distribution of phospholipid speciesin the outer surlace of the piatelet membrane. ihe model
1loryn in Fig. 7 shows a membrane protein that induces afl ip-flop reaction for phosphatid-vlserine (pS) molecules andthus acts as a source ol PS at the outer surface. Such a pro-tein also might induce a clustering of pS molecules aroundthe source- In later stages of the p6.es the pS might diffuse
more freely in the outer platelet surface, and in this wavform areas lavourable for the prothrombin u.t,uutioi.Since the. lactor Xo generated n.a. the source acts as an en_
zyme., it is a possibil i ty that this enzyme does not leave thepraiclet atmosDhere.
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